Literature DB >> 14695848

Hematopoietic growth factors for acute myelogenous leukemia.

Matt Kalaycio.   

Abstract

Entities:  

Year:  2004        PMID： 14695848     DOI： 10.1007/s11901-004-0007-8

Source DB:  PubMed          Journal:  Curr Hematol Rep        ISSN： 1540-3408


× No keyword cloud information.
  36 in total

1.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

Authors:  D R Taylor; S T Shi; P R Romano; G N Barber; M M Lai
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

2.  Viral heterogeneity of the hepatitis C virus.

Authors:  P Simmonds
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

3.  Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa.

Authors:  N P Lam; A U Neumann; D R Gretch; T E Wiley; A S Perelson; T J Layden
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

Review 4.  Retreatment of patients with chronic hepatitis C.

Authors:  Mitchell L Shiffman
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Treatment of acute hepatitis C with interferon alfa-2b.

Authors:  E Jaeckel; M Cornberg; H Wedemeyer; T Santantonio; J Mayer; M Zankel; G Pastore; M Dietrich; C Trautwein; M P Manns
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

6.  Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.

Authors:  Eileen Foy; Kui Li; Chunfu Wang; Rhea Sumpter; Masanori Ikeda; Stanley M Lemon; Michael Gale
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

7.  In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.

Authors:  Caterina Trozzi; Linda Bartholomew; Alessandra Ceccacci; Gabriella Biasiol; Laura Pacini; Sergio Altamura; Frank Narjes; Ester Muraglia; Giacomo Paonessa; Uwe Koch; Raffaele De Francesco; Christian Steinkuhler; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response.

Authors:  G W Witherell; P Beineke
Journal:  J Med Virol       Date:  2001-01       Impact factor: 2.327

10.  Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.

Authors:  J M Pawlotsky; G Germanidis; A U Neumann; M Pellerin; P O Frainais; D Dhumeaux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.